Kura Oncology Inc
KURA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.12B
Close$
$14.49
10.2% upside
Current Fair Value
10.2% upsideUndervalued by 10.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.12 Billion |
|---|---|
| Enterprise Value | $1.13 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.18 |
| Beta | 0.38 |
| Outstanding Shares | 88,855,000 |
Return
| Return on Equity | -612.78% |
|---|---|
| Return on Assets | -50.49% |
| Return on Invested Capital | -66.66% |
Valuation & Multiples
| P/E Ratio | -3.76 |
|---|---|
| PEG | -112.65 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 14.68 |
| Enterprise Value to EBIT | -3.62 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 1.65 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.88
Average shareholder expectationRevenue Estimate
$20.16 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.84
Average shareholder expectationRevenue Estimate
$23.80 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1846▼ 81.45% |
|---|---|
| Total Calls | 439,900▲ 102.35% |
| Total Puts | 81,200▼ 62.62% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 99.93%▲ 4.65% |
|---|---|
| Total Invested | $1.05B▲ 53.30% |
| Investors Holding | 226▼ 2.00% |
ESG Score
No data
About Kura Oncology Inc
CEO: Troy Wilson